Spring Mountain Capital
VC Fund
New York, United States
Spring Mountain Capital is a VC fund in New York focused on Health Care and Software. Spring Mountain Capital focuses on providing expansion capital to companies capitalizing on breakthrough innovations, paradigm shifts, or fundamental market or behavioral changes. SMC invests in sectors of the U.S. economy undergoing the most change and with the highest growth potential: enterprise software, technology-enabled services, digitalhealth, and healthcare services.
- Total investments:
- 57
- Last investment:
- Lead investor:
- 58%
- Fund size:
- $125M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Spring Mountain Capital invests in
Stages Spring Mountain Capital invests in
Countries Spring Mountain Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Health Care 12 (21%)
- Software 8 (14%)
- Biotechnology 8 (14%)
- Medical 7 (12%)
- Information Technology 6 (11%)
Stage
- Series B 20 (35%)
- Series A 16 (28%)
- Series C 6 (11%)
- Funding Round 4 (7%)
- Seed 3 (5%)
Country
- United States 36 (63%)
- Canada 2 (4%)
- China 1 (2%)
- Switzerland 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Gregory Ho
President and Chief Operating Officer
|
President and Chief Operating Officer | Total investments: 6 | Find email | |
Jamie Weston
Managing Director
|
Managing Director | Total investments: 11 | Find email | |
John Gu
Principal
|
Principal | Total investments: 1 | Find email | |
John Steffens
Founder & Senior Managing Director
|
Founder & Senior Managing Director | Total investments: 4 | Find email | |
Kenneth Soll
Vice President
|
Vice President | Total investments: 2 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
xCures
|
The convergence of genomics, precision medicine, and AI have created an unprecedented moment in the world of oncology. But the drug-centric way in which treatments are developed and the haphazard way in which knowledge about those treatments is captured and delivered to the point of care does not serve patients well. xCures is changing that, withan AI-based precision oncology platform that tightly integrates cancer research and care.The xCures platform runs a perpetual trial that captures Real World Evidence (RWE) to continuously learn from all patients, on all treatments, all the time. It coordinates treatment recommendations across all patients and institutions to match patients with the treatments that work. And it packages RWE for use by stakeholders across oncology, slashing the time and cost of drug development and saving lives. | $46M / Series B / Jun 24, 2026 | |
Yunu
|
Yunu is a med-tech company that develops a platform to access clinical trial and experiment data with researchers and doctors worldwide. | Seed / Apr 16, 2025 | |
Hiveclass
|
Hiveclass Encourage kids to play, run, jump and connect with other athletes while learning new techniques, mastering tricks, and having fun. | $1.5M / Seed / Feb 07, 2025 | |
Wingtra
|
Wingtra is a professional drone manufacturer based in Zurich, Switzerland. The company produces the VTOL WingtraOne drone, which collects high-precision aerial data for surveying and mapping applications. Since its market entry in 2017, Wingtra has partnered with more than 50 of the biggest surveying equipment dealers across the globe, such as RDOInc. and SITECH. | Series B / Aug 15, 2024 | |
BinSentry
|
BinSentry is an agricultural technology company developing an innovative Internet of Things (IoT) solution which enables feed mills and livestock producers to effectively monitor on-farm inventory, dramatically increasing operational efficiencies. It was founded in 2017 and is based in Kitchener, Canada. | $15M / Series B / Aug 13, 2024 | |
Thentia Cloud
|
Thentia Corporation is an industry leader in using proprietary technology to help regulatory bodies efficiently fulfill their regulatory obligations. Thentia services a wide variety of clients throughout Canada and the United States using cutting-edge software and industry-leading expertise in regulatory standards. | $38M / Series B / Jan 25, 2024 | |
showd.me
|
showd.me is an enterprise peer-to-peer learning platform that allows employees to learn from, and train, other employees across the organization. With cross-platform tools such as keyword skill search, chat, video, file sharing, email integration and more, organizations can easily onboard and train new hires, develop employee expertise and identifynew career paths. | Series A / Sep 27, 2023 | |
ProSomnus Sleep Technologies
|
ProSomnus designs and manufactures intraoral devices designed to help dentists get patients into therapy faster, with greater comfort, and treatment effectiveness. Its flagship products are the ProSomnus [IA] and MicrO2 Sleep, and Snore Devices. Its devices are the first, precision oral appliance therapy devices designed to enhance compliance,mitigate side effects, and enable dentists to achieve excellent patient experiences and outcomes. The company was founded in 2016 and is headquartered in Pleasanton, California. | $10M / Post-IPO Equity / Sep 21, 2023 | |
Rayleigh Acoustics
|
Rayleigh Acoustics is a sound beautification design service provider. | $13.1M / Series A / Feb 21, 2023 | |
Recess
|
Recess is an experiential partnership marketing platform helping advertisers engage and acquire new customers via event and venue partnerships at-scale. This all-in-one solution allows brands and agencies to discover, execute, and measure experiential partnerships with thousands of events and venues, using a single platform. Recess offers turnkeyitem distribution as well as the ability to activate on-site for brands with field teams or agencies that want to engage directly with 230M+ consumers. With smart targeting, centralized contracting, payment and logistics, Recess customers are saving countless hours and driving measurable ROI. | $5M / Series A / Nov 10, 2022 | |
| See all 57 investments → | |||
Co-Investors
Portfolia
6 deals together
BDC ICE Fund (Cleantech)
4 deals together
Colle Capital Partners
4 deals together
Connecticut Innovations
4 deals together
14W
3 deals together
Blue Heron Capital
3 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Spring Mountain Capital invest in?
Spring Mountain Capital invests primarily in Health Care, Software and Biotechnology startups, most often at Series B and Series A stage. Most of the 57 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Spring Mountain Capital?
Public channels for Spring Mountain Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Spring Mountain Capital?
The team at Spring Mountain Capital includes Gregory Ho (President and Chief Operating Officer), Jamie Weston (Managing Director) and John Gu (Principal), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
